We are live on
!
Find out more
LIM
Lagoda Investment Management Portfolio holdings
AUM
$162M
1-Year Est. Return
49.7%
This Fund
S&P 500
This Quarter
Est. Return
+9.16%
1 Year Est. Return
+49.7%
3 Year Est. Return
+193.16%
5 Year Est. Return
+230.21%
10 Year Est. Return
+1,614.49%
AUM
$262M
AUM Growth
+$4.12M
(+1.6%)
Cap. Flow
-$9.99M
Cap. Flow
% of AUM
-3.82%
Top 10 Holdings %
Top 10 Hldgs %
77.55%
Holding
40
New
4
Increased
13
Reduced
13
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booking.com
BKNG
|
+$14.5M |
| 2 |
XEC
CIMAREX ENERGY CO
XEC
|
+$7.87M |
| 3 |
WD-40
WDFC
|
+$7.09M |
| 4 |
Trupanion
TRUP
|
+$2.37M |
| 5 |
Digimarc Corp
DMRC
|
+$1.88M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PTC
PTC
|
+$18.3M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$12.4M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$6.43M |
| 4 |
RenaissanceRe
RNR
|
+$5.28M |
| 5 |
Precigen
PGEN
|
+$4.49M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 32.69% |
| 2 | Technology | 22.08% |
| 3 | Communication Services | 12.29% |
| 4 | Financials | 11.35% |
| 5 | Materials | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Brown-Forman Class B
BF.B
$13.1B
| $205K | 0.08% |
6,575
| – | – |
|
27
Mastercard
MA
$493B
| $196K | 0.07% |
1,610
-175
| -10% | -$20.8K |
|
28
ExxonMobil
XOM
$634B
| $179K | 0.07% |
2,215
| – | – |
|
29
Coca-Cola
KO
$375B
| $168K | 0.06% |
3,750
-200
| -5% | -$8.84K |
|
30
SPDR Gold Trust
GLD
$141B
| $106K | 0.04% |
900
| – | – |
|
31
Johnson & Johnson
JNJ
$625B
| $79K | 0.03% |
600
-300
| -33% | -$38.3K |
|
32
Las Vegas Sands
LVS
$29.6B
| $73K | 0.03% |
1,150
-200
| -15% | -$12K |
|
33
Procter & Gamble
PG
$339B
| $60K | 0.02% |
690
| – | – |
|
34
ConocoPhillips
COP
$141B
| $54K | 0.02% |
1,231
| – | – |
|
35
Pfizer
PFE
$153B
| $41K | 0.02% |
1,292
| – | – |
|
36
AbbVie
ABBV
$435B
| $35K | 0.01% |
489
+163
| +50% | +$11K |
|
37
Abbott
ABT
$187B
| $31K | 0.01% |
639
+213
| +50% | +$9.64K |
|
38
AquaBounty Technologies
AQB
$6.02M
| $16K | 0.01% |
100
| – | – |
|
39
Phillips 66
PSX
$81.4B
| $16K | 0.01% |
197
| – | – |
|
|
MACK
40
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| – | – |
-98,575
| Closed | -$2.39M |
|
Similar funds
AXA
KCPT
TFP
CWMGO
SWMG
TIAM2
GPA
FC
Lagoda Investment Management's Q2 2017 Portfolio in Review
As of Q2 2017, Lagoda Investment Management held 40 positions worth $262M, up 1.6% from $258M the previous quarter. Its ten largest holdings account for 78% of the portfolio.
Lagoda Investment Management withdrew a net $9.99M in Q2 2017, closing 1 position and reducing 13 holdings. Its most notable exit was Merrimack Pharmaceuticals, Inc., an estimated $2.39M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 41% a quarter earlier, followed by Technology and Communication Services.
Against the trend, Lagoda Investment Management opened a new position in Booking.com worth $14.8M.
- Lagoda Investment Management's largest Q2 2017 buy was Booking.com: 197,850 shares worth $14.8M.
- Lagoda Investment Management added most to Digimarc Corp in Q2 2017, an estimated $1.88M increase.
- Lagoda Investment Management's biggest Q2 2017 reduction was PTC, cutting an estimated $18.3M.
- Lagoda Investment Management fully exited Merrimack Pharmaceuticals, Inc. in Q2 2017, selling an estimated $2.39M.
- Lagoda Investment Management's ten largest holdings make up 78% of its $262M portfolio in Q2 2017.
- Lagoda Investment Management opened 4 new positions and closed 1 in Q2 2017.
- Lagoda Investment Management's portfolio value rose 1.6% quarter-over-quarter to $262M.
Based on Lagoda Investment Management's 13F filing for Q2 2017, filed 14 Aug 2017.